Role of Adjuvant Radiotherapy in Acinic Cell Carcinoma of the Salivary Glands: A Systematic Review

Clin Oncol (R Coll Radiol). 2023 Sep;35(9):e489-e497. doi: 10.1016/j.clon.2023.06.011. Epub 2023 Jun 16.

Abstract

A systematic review was carried out to evaluate if adjuvant radiotherapy for acinic cell carcinomas (ACCs) of salivary glands improves survival. Twelve retrospective studies published between 2000 and 2020 that analysed the effect of radiotherapy on salivary gland neoplasms and ACCs of salivary glands and met the inclusion criteria were included in the review. The overall quality of the studies was moderate to low. There was no high-quality evidence for improved survival with radiotherapy for ACCs of the salivary gland. Some evidence suggests that there may be an advantage for patients with high-grade tumours, but these data should be interpreted with caution due to the small number of patients and low-quality evidence. Good quality of evidence is lacking. Recommendation for adjuvant radiotherapy for tumours with poor prognostic factors will require discussion and shared decision-making with the patients.

Keywords: Acinic cell carcinoma; adjuvant radiotherapy; risk factors; salivary gland cancer; survival.

Publication types

  • Systematic Review

MeSH terms

  • Carcinoma, Acinar Cell* / pathology
  • Carcinoma, Acinar Cell* / radiotherapy
  • Humans
  • Radiotherapy, Adjuvant
  • Retrospective Studies
  • Salivary Gland Neoplasms* / pathology
  • Salivary Gland Neoplasms* / radiotherapy
  • Salivary Glands / pathology